C. M. P. W. Mandigers

Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation

C. M. P. W. Mandigers, Leo F. Verdonck, Jules P.P. Meijerink et al. · Bone Marrow Transplantation · 2003 · 98 citations

Transplantation, Marrow Transplantation, Medicine +12

New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide

Wim van Boxtel, Ben F. Bulten, Annelies M. C. Mavinkurve‐Groothuis et al. · Biomarkers · 2015 · 60 citations

MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study

Anna van der Voort, Fleur M. Louis, Mette S. van Ramshorst et al. · The Lancet Oncology · 2024 · 36 citations · Full text

Neoadjuvant Chemotherapy Duration, Breast Oncology, Medical Imaging +10

Renal replacement therapy in the elderly

C. M. P. W. Mandigers · The Netherlands Journal of Medicine · 1996 · 19 citations

Glomerulonephritis, Hemodialysis, Urology +10

Safety, pharmacokinetics (PK), and cost-effectiveness of upfront genotyping of <i>DPYD</i> in fluoropyrimidine therapy.

Maarten J. Deenen, Annemieke Cats, Marjolein K. Sechterberger et al. · Journal of Clinical Oncology · 2011 · 18 citations

Upfront Genotyping, Pharmacotherapy, Fluoropyrimidine Exposure +22